ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection
December 04, 2018CASI Pharmaceuticals Executive Chairman Wei-Wu He, Ph.D., commented, "NMPA approval of Melphalan Hydrochloride For Injection (EVOMELA®) is encouraging news for patients in China with multiple myeloma as there is no commercially available melphalan formula -
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection
December 04, 2018CASI Pharmaceuticals Executive Chairman Wei-Wu He, Ph.D., commented, "NMPA approval of Melphalan Hydrochloride For Injection (EVOMELA®) is encouraging news for patients in China with multiple myeloma as there is no commercially available melphalan formula -
DRL launches melphalan hydrochloride for injection in US market
December 27, 2017The injection is available in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride
Pharma Sources Insight January 2025
